Literature DB >> 9344595

Reconstruction of peritoneal-like structure in three-dimensional collagen gel matrix culture.

F Bittinger1, C Brochhausen, C Skarke, H Köhler, C J Kirkpatrick.   

Abstract

The peritoneum is a serous membrane consisting of different kinds of cells and extracellular matrix components (ECM). The aim of the present study was to develop a three-dimensional (3D) in vitro culture system for possible investigation of pathological conditions of the peritoneum. Human omental mesothelial cells (MC) and endothelial cells from the umbilical vein (EC) were cultivated either on (MC) or in (EC) a preformed type I collagen matrix. In 3D culture mesothelial cells showed their phenotypical in vivo characteristics and the synthesis of a new basal membrane (BM). Endothelial cells developed vessel-like structures, produce a BM and express E-selectin after TNF-alpha stimulation. This 3D culture system presents extended possibilities for analyzing mesothelial and endothelial cell behavior as well as the cell-cell and cell-matrix interactions involved in several pathological processes in the peritoneum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344595     DOI: 10.1006/excr.1997.3724

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  Conference report--extracellular matrix and cancer: revisiting metalloproteinases highlights from the annual meeting of the American Society for Cell Biology; December 13-17, 2003; San Francisco, California.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-02-23

2.  Mesothelial morphology and organisation after peritoneal treatment with solid and liquid adhesion barriers--a scanning electron microscopical study.

Authors:  Christoph Brochhausen; Volker H Schmitt; Taufiek K Rajab; Constanze N E Planck; Bernhard Krämer; Christine Tapprich; Markus Wallwiener; Helmut Hierlemann; Heinrich Planck; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2012-05-10       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.